Targeting the immune system to cancer

Human cancers represent heterogeneous populations of cells whose genomes constantly change , so targeted therapies must be aimed at continuously changing networks. To overcome this difficulty a most promising strategy has been developed, which involves using a ligand‐guided vector carrying a double‐...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Polymers for advanced technologies 2011-01, Vol.22 (1), p.99-102
Hauptverfasser:	Levitzki, Alexander, Shir, Alexei
Format:	Artikel
Sprache:	eng
Schlagworte:	cancer dsRNA EGFR immunotherapy targeted therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!